Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-004951

President & COO sold 435,425 shares at an average $10.47 ($4,561,041)

  • President & COO acquired 600,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Venker Eric · President & COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-12 Exercise or conversion : show line 1 in the form +300,000 $3.85 $1,155,000 1,032,294 D
2025-02-12 Sale : show line 2 in the form −217,384 $10.53 $2,289,054 732,294 D
2025-02-13 Exercise or conversion : show line 3 in the form +300,000 $3.85 $1,155,000 1,114,910 D
2025-02-13 Sale : show line 4 in the form −218,041 $10.42 $2,271,987 896,869 D
Open-market sales · 435,425 sh · avg $10.47 · $4,561,041

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-12 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −300,000 11,326,234 D
2025-02-13 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −300,000 11,026,234 D
Loading xslF345X05/form4.xml…